Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Follows young people at high risk of psychosis in a step-based care program

Studies long-term outcomes of a step-based care program for young people at clinical high risk.

Plain-language title generated from the registry record
Registry title: Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis

Key facts

Where
Columbus, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 25 years old?

Source: NCT03970005, who can take part

Where in United States

  • OSU Harding HospitalColumbus, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ohio State University
Trial code
NCT03970005
Record updated
14 October 2026
Original description
The Ohio State University Early Psychosis Intervention Center is implementing a specialized clinical program to serve individuals who meet clinical high risk criteria for a psychosis. The purpose of this study is to evaluate the long-term outcomes among individuals participating in this clinical service.Read full original descriptionShow less

Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis

The Ohio State University Early Psychosis Intervention Center is implementing a specialized clinical program to serve individuals who meet clinical high risk criteria for a psychosis. The purpose of this study is to evaluate the long-term outcomes among individuals participating in this clinical service.

Inclusion: Male and female patients between ages 12-25; Individuals meeting clinical high-risk criteria for psychosis as determined using the Structured Interview for Psychosis Risk. Inclusive of individuals meeting any of the three CHR syndromes assessed by the SIPS (i.e., attenuated psychotic symptoms; brief intermittent psychosis, and genetic risk and functional deterioration) and/or individuals at all four current status specifiers for the SIPS (i.e., progression, persistence, partial remission, and full remission) given evidence that future worsening of symptoms and/or progression to psychosis is possible for individuals in each current status specifier category; Subjects with no evidence of a pre-existing intellectual disability defined as a premorbid IQ >70 as estimated using the Reading subtest of the Wide Range Achievement Test-4; Fluent in English per self-report.

ClinicalTrials.gov NCT03970005